(from the Reuters Fact Check dust of Jan 12, 2022)
“Missing context. The CDC’s Director Rochelle Walensky did not say that 75% of all COVID-19 deaths were among people with at least four risk factors. In comments around vaccine efficacy, Walensky said that a CDC study found that over 75% of deaths among fully vaccinated people were among those with at least four comorbidities.”*If “over 75% of [COVID?] deaths among fully vaccinated people were among those with at least four comorbidities” what are the possible conclusions? And how might we create, whether deliberately or inadvertently, a false flag by latching onto one paramount “cause of death” to the exclusion of other causes?
1) Did breakthrough COVID cause the death?Do we see how easy it is to exonerate or blame particular cause(s), depending on the uncertainties and confirmation bias?
2) Did a comorbidity cause the death which in its absence, the patient would have recovered from the breakthrough COVID?
3) Did one or more of the vaccines cause the breakthrough?
4) Did one or more of the vaccines cause the death? e.g., via ADE?**
5) Did one or more of the vaccines exacerbate a comorbidity causing death?
6) etc.
Have we seen any evidence of false-flagging from the pandemic dust of 2020 & 2021?
----------------------------------------------/
*https://www.reuters.com/article/factcheck-walensky-study/fact-check-cdc-study-found-that-over-75-of-covid-19-deaths-in-vaccinated-people-were-among-those-with-at-least-4-comorbidities-idUSL1N2TS0S2
**Antibody-dependent enhancement (ADE), sometimes less precisely called immune enhancement or disease enhancement, is a phenomenon in which binding of a virus to suboptimal antibodies enhances its entry into host cells, followed by its replication.[1][2] The suboptimal antibodies can result from natural infection or from vaccination. ADE may cause enhanced respiratory disease and acute lung injury after respiratory virus infection (ERD) with symptoms of monocytic infiltration and an excess of eosinophils in respiratory tract.[3] ADE along with type 2 T helper cell-dependent mechanisms may contribute to a development of the vaccine associated disease enhancement (VADE), which is not limited to respiratory disease.[3] Some vaccine candidates that targeted coronaviruses, RSV virus and Dengue virus elicited VADE, and were terminated from further development or became approved for use only for patients who had those viruses before. | https://en.wikipedia.org/wiki/Antibody-dependent_enhancement